HCW Biologics (HCWB) Receivables (2020 - 2025)
HCW Biologics' (HCWB) quarterly Receivables came in at $32175.0 in Q4 2025, down 94.47% YoY from $582201.0 in Q4 2024, and up 4.92% on a QoQ basis from $30667.0 in Q3 2025.
HCW Biologics (HCWB) Receivables (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Receivables data on file, last reported at $32175.0 in Q4 2025.
- Quarterly Receivables fell 94.47% year-over-year to $32175.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $32175.0 (down 94.47% YoY) and the FY2025 annual result came in at $32175.0, down 94.47% from the prior year.
- Receivables climbed to $32175.0 in Q4 2025, from $30667.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $1.5 million in Q4 2023 to a low of $21611.0 in Q2 2025.
- A 5-year average of $426147.8 and a median of $355555.0 in 2022 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables soared 593.87% — and 2025, when it tumbled 96.7%.
- Tracing HCWB's Receivables over 5 years: stood at $133000.0 in 2021, then soared by 214.06% to $417695.0 in 2022, then surged by 267.67% to $1.5 million in 2023, then plunged by 62.09% to $582201.0 in 2024, then slumped by 94.47% to $32175.0 in 2025.
- The last three Receivables figures came in at $32175.0 (Q4 2025), $30667.0 (Q3 2025), and $21611.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | 18,451.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 32,175.00 |
| Sep 30, 2025 | 30,667.00 |
| Jun 30, 2025 | 21,611.00 |
| Mar 31, 2025 | 87,493.00 |
| Dec 31, 2024 | 582,201.00 |
| Sep 30, 2024 | 651,840.00 |
| Jun 30, 2024 | 654,973.00 |
| Mar 31, 2024 | 903,884.00 |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 710,078.00 |
| Jun 30, 2023 | 707,211.00 |
| Mar 31, 2023 | 252,728.00 |
| Dec 31, 2022 | 417,695.00 |
| Sep 30, 2022 | 355,555.00 |
| Jun 30, 2022 | 346,934.00 |
| Mar 31, 2022 | 553,007.00 |
| Dec 31, 2021 | 133,000.00 |
| Sep 30, 2021 | 70,000.00 |
| Jun 30, 2021 | 50,000.00 |
| Dec 31, 2020 | 2.50 Mn |